Galectin Therapeutics Inc (GALT)
0.802
-0.09
(-9.90%)
USD |
NASDAQ |
Dec 24, 11:46
Galectin Therapeutics Shareholders Equity (Quarterly): -92.48M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alaunos Therapeutics Inc | 2.724M |
| SELLAS Life Sciences Group Inc | 15.89M |
| Oragenics Inc | 3.078M |
| Anavex Life Sciences Corp | 129.78M |
| Phathom Pharmaceuticals Inc | -187.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.97M |
| Total Liabilities (Quarterly) | 121.45M |